These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 15804788)

  • 1. Clinical pharmacokinetics of lyophilized recombinant human erythropoietin-alpha following single-dose subcutaneous administration in premature newborns.
    Melo AM; Costa MT; Porta V; Vaz FA
    J Matern Fetal Neonatal Med; 2005 Jan; 17(1):55-8. PubMed ID: 15804788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
    Smith WB; Dowell JA; Pratt RD
    Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and pharmacodynamics of recombinant human erythropoietin after single and multiple subcutaneous doses to healthy subjects.
    Cheung WK; Goon BL; Guilfoyle MC; Wacholtz MC
    Clin Pharmacol Ther; 1998 Oct; 64(4):412-23. PubMed ID: 9797798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study.
    Zhao RK; Cheng G; Tang J; Song J; Peng WX
    Clin Ther; 2009 May; 31(5):1022-36. PubMed ID: 19539103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of recombinant human erythropoietin in rabbits and 3/4 nephrectomized rats.
    Yoon WH; Park SJ; Kim IC; Lee MG
    Res Commun Mol Pathol Pharmacol; 1997 May; 96(2):227-40. PubMed ID: 9226757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic-pharmacodynamic modelling of recombinant human erythropoietin in athletes.
    Varlet-Marie E; Gaudard A; Audran M; Gomeni R; Bressolle F
    Int J Sports Med; 2003 May; 24(4):252-7. PubMed ID: 12784166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase I/II trial of high-dose erythropoietin in extremely low birth weight infants: pharmacokinetics and safety.
    Juul SE; McPherson RJ; Bauer LA; Ledbetter KJ; Gleason CA; Mayock DE
    Pediatrics; 2008 Aug; 122(2):383-91. PubMed ID: 18676557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers.
    Alkhalidi BA; Tamimi JJ; Salem II; Ibrahim H; Sallam AA
    Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic and pharmacodynamic modeling of recombinant human erythropoietin after intravenous and subcutaneous administration in rats.
    Woo S; Krzyzanski W; Jusko WJ
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1297-306. PubMed ID: 16973883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of several subcutaneous doses of erythropoietin: potential implications for blood transfusion.
    Sans T; Joven J; Vilella E; Masdeu G; Farrè M
    Clin Exp Pharmacol Physiol; 2000 Mar; 27(3):179-84. PubMed ID: 10744344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic and pharmacodynamic modeling of recombinant human erythropoietin after single and multiple doses in healthy volunteers.
    Ramakrishnan R; Cheung WK; Wacholtz MC; Minton N; Jusko WJ
    J Clin Pharmacol; 2004 Sep; 44(9):991-1002. PubMed ID: 15317827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and haematological parameters of recombinant human erythropoietin after subcutaneous administrations in horses.
    Souillard A; Audran M; Bressolle F; Jaussaud P; Gareau R
    Biopharm Drug Dispos; 1996 Dec; 17(9):805-15. PubMed ID: 8968532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smoking behaviour modulates pharmacokinetics of orally administered clopidogrel.
    Yousef AM; Arafat T; Bulatova NR; Al-Zumyli R
    J Clin Pharm Ther; 2008 Aug; 33(4):439-49. PubMed ID: 18613862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of buprenorphine following intravenous administration in dogs.
    Krotscheck U; Boothe DM; Little AA
    Am J Vet Res; 2008 Jun; 69(6):722-7. PubMed ID: 18518651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gestational age dependency in the prenatal toxicity and in the disposition kinetics of the novel anticonvulsant HEPP (D,L-3-hydroxy-3-ethyl-3-phenylpropionamide) after subcutaneous administration in pregnant rats.
    Gómez-Martínez LE
    Int J Toxicol; 2007; 26(3):237-46. PubMed ID: 17564905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of low-dose doxorubicin and metabolites in patients with AIDS-related Kaposi sarcoma.
    Joerger M; Huitema AD; Meenhorst PL; Schellens JH; Beijnen JH
    Cancer Chemother Pharmacol; 2005 May; 55(5):488-96. PubMed ID: 15726371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of erythropoietin following single-dose subcutaneous administration in preterm infants.
    Krishnan R; Shankaran S; Krishnan M; Kauffman RE; Kumar P; Lucena J
    Biol Neonate; 1996; 70(3):135-40. PubMed ID: 8894079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase I, randomized, open-label, crossover study of the single-dose pharmacokinetic properties of guanfacine extended-release 1-, 2-, and 4-mg tablets in healthy adults.
    Swearingen D; Pennick M; Shojaei A; Lyne A; Fiske K
    Clin Ther; 2007 Apr; 29(4):617-25. PubMed ID: 17617285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Suitability of the peroral administration of the marker creatinine for the quantitative determination of the glomerular filtration rate (GFR) in dogs].
    Hartmann H; Baumgardt T; Höchel J
    Berl Munch Tierarztl Wochenschr; 2006; 119(1-2):62-7. PubMed ID: 16450711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic and pharmacodynamic studies following percutaneous absorption of erythropoietin micropiles to rats.
    Ito Y; Shiroyama K; Yoshimitsu J; Ohashi Y; Sugioka N; Takada K
    J Control Release; 2007 Aug; 121(3):176-80. PubMed ID: 17628163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.